Chronic Immune Thrombocytopenia Clinical Trials in Zhengzhou, Henan

A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia